Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
-
1121
-
1122
-
1123
Transgenic expression of SPDEF in prostate epithelium decreased prostate carcinogenesis.
Published 2014“…Data represent mean ± SD. A <i>p</i> value<0.01 is shown with (**) and <i>p</i> value<0.05 is shown with (*). …”
-
1124
-
1125
-
1126
-
1127
-
1128
-
1129
Damage accumulation decreases elongation rates and displaces growth equilibrium.
Published 2019“…<p>All panels depict MG1655 wild-type <i>E</i>. <i>coli</i>. (A) Exposure to phototoxic damage led to decreasing elongation rates in all treatment levels (length of exposure, every 2 min: 70 ms, 700 ms, 1 s, 1.5 s, 3 s). …”
-
1130
-
1131
-
1132
-
1133
Functional Annotation and pathway analysis of genes decreased more than 2-fold in Cr(VI) transformed cells.
Published 2011“…<p>Functional Annotation and pathway analysis of genes decreased more than 2-fold in Cr(VI) transformed cells.…”
-
1134
-
1135
-
1136
-
1137
-
1138
Ubiquitin ligases of the rat pineal gland whose expression is decreased at least 2-fold at night in the Hartley dataset.
Published 2017“…<p>Ubiquitin ligases of the rat pineal gland whose expression is decreased at least 2-fold at night in the Hartley dataset.…”
-
1139
-
1140
CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line.
Published 2014“…Immortalized HBECs with (A) lenti-<i>KRas</i><sup>V12</sup>, (B) lenti-<i>KRas</i><sup>V12</sup> and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i><sup>V12</sup>, sh<i>p53</i>, and <i>myc</i> overexpression. …”